Forbes - Healthcare

While researchers have spent decades searching for malaria vaccines, only two have ever been authorized, a situation many scientists hope to change as they race to leverage new technology against one of humanity’s oldest and deadliest foes.

Ro co-founder and CEO Z Reitano joins Brittany Lewis on “Forbes Talks” to discuss the national shortage of Wegovy, a weight loss drug, and what he thinks needs to be done to “overhaul” the entire U.S. health care system.

The Food and Drug Administration on Thursday approved the first ever over-the-counter birth control daily pill, a major development amid a heightened debate over contraception in the wake of the Supreme Court’s momentous decision last summer.

The manufacturer of a generic version of the abortion drug mifepristone sued the Food and Drug Administration on Wednesday to prevent any new restrictions on the pill.

Researchers on Monday announced promising results for a tuberculosis vaccine that can be freeze-dried and safely stored at higher temperatures for months, hailing a major breakthrough in the fight against one of humanity’s biggest killers.

China and a number of other countries have suspended imports of Brazilian beef after a case of mad cow disease was confirmed last month, sparking concern for the country’s crucial livestock sector as experts move rapidly to investigate the disease.

The bird flu outbreak is the deadliest one in almost 10 years—which has helped cause egg prices to steeply rise—and while infection in humans is rare, some experts are gravely concerned it could eventually make the leap and spread among humans.

The Biden administration will bring the years-long Covid-19 emergency declarations to an end on May 11, the White House announced Monday, as part of a pivot to treat the coronavirus as an endemic seasonal threat.

The Federal Bureau of Investigation on Thursday began offering rewards of up to $25,000 for information about a series of attacks on at least 10 reproductive health care facilities across the U.S. last year.

U.S. pharma giant Pfizer on Tuesday said it will make its entire portfolio of drugs and vaccines available to low-income countries on a not-for-profit basis, significantly expanding an earlier scheme.